Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the record history UI. This update is administrative and does not alter trial data or text.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew revision v3.5.2 was added and v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check55 days agoChange Detected- Revision v3.5.0 added to the Record History, and revision v3.4.3 removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.4.3 to the Record History and crossed out Revision: v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision v3.4.2 was added to the history log and Revision v3.4.1 was removed. These are site-wide updates and notices rather than changes to trial data or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check97 days agoChange DetectedAdded a government funding/status notice and the new site revision tag v3.4.1, and removed the previous revision tag v3.4.0.SummaryDifference0.9%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.